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Abstract
Melatonin possesses the indoleamine structure and exerts antioxidant and anti-inflammatory actions and other physi‑
ological properties. Physical exercise can influence secretion of melatonin. Melatonin is used as a natural supplement
among athletes to regulate sleep cycles and protect muscles against oxidative damage. Despite decades of research,
there is still a lack of a comprehensive and critical review on melatonin supplementation and physical activity relation‑
ship. The aim of this literature review is to examine the antioxidant, anti-inflammatory and other biological functions
played by melatonin with reference to the effect of physical exercise on melatonin secretion and the effect of this
compound supplementation on exercise-induced oxidative stress in athletes. Evidence shows that intense exercises
disturb antioxidant status of competitive athletes, whereas supplementation with melatonin strengthens antioxidant
status in trained athletes in various sports as the compound showed high potency in reduction of the oxidative stress
and inflammation markers generated during intense and prolonged exercise.
Keywords: Melatonin, Bioactivity, Oxidative stress, Inflammation, Exercise, Supplementation
Background
Melatonin (MT) N-acetyl-5-methoxytryptamine is an
endogenous indoleamine which controls crucial physiological processes such as human circadian rhythms
sleep–wake cycle, anxiety, immune, and cardiac function [1–5]. MT influences appetite and regulates insulin
levels among other functions [6]. The compound and its
metabolites are potent antioxidants which exhibit antiinflammatory properties and protect mitochondria from
damage by scavenging reactive oxygen species (ROS),
and reactive nitrogen species (RNS) [7–9]. MT and its
derivatives stimulate several antioxidant enzymes activity
[1, 10]. Thus, MT plays an important role in maintenance
of cellular redox homeostasis and in the aging processes.
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Increase in free radicals’ level and oxygen non-radical
species production, followed by their accumulation in
cells, may lead to a disturbance in cellular redox balance;
a phenomenon called oxidative stress (OS). This state is
characterized by an imbalance between pro-oxidants
generation and antioxidant system’s defense against ROS/
RNS and efficiency of the DNA repair system [11].
Intense physical activity (PA), similarly as other
unhealthy lifestyle factors such as smoking, alcohol,
improper diet, or environmental factors (e.g., radiation,
viruses, and bacteria), disturbs the redox homeostasis
toward oxidation [12, 13]. Intense and prolonged exercise
induces inflammation, due to high generation of free radicals and ROS/RNS and possible oxidative muscle damage [14, 15]. In contrast, regular moderate-to-vigorous
exercise generates moderate concentration of ROS/RNS,
followed by adaptative responses favorable for the organism and exert beneficial effects on onset and progression
of a number ROS/RNS-associated diseases [16–18]. The
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redox homeostasis in the skeletal muscle is key, in the
context of sports, because the redox state depends on
efficacy of ROS generation [16].
There is growing evidence that physical exercise (PE)
may exert both rapid and delayed (12–24 h) effects on
human MT secretion [19, 20].
In a previous article, we presented the enhancing effect
of PE on catecholamines (CATs) secretion and on cellular
redox homeostasis [21]. Evidence has shown that one of
the CATs, noradrenaline (NA), is involved in the control
of MT synthesis. Due to antioxidant properties MT and
its metabolites, and the compound prescription in sleep
disturbances of children and adolescents in neuropsychiatric disorders [22] and common ingestion by athletes,
presenting the current state of knowledge on association
between MT and PE is warranted. The potential of MT as
an antioxidant to supplement against negative effects of
exhaustive and/or high intense PE or to improve athlete’s
performance is necessary. Despite increasing research in
this field, there is a lack of a comprehensive critical summary of the research on impact of MT supplementation
to prevent against the PE-induced OS. Therefore, this
article presents a representative cross-section of evidence
in this area. The aim of this paper is to present the effect
of PE on MT secretion and to demonstrate the current
evidence on the beneficial role of the indolamine supplementation against OS generated in the human body by
strenuous exercise. This review also focuses on mechanisms and determinants of exercise-induced OS and
summarizes the literature data on biological functions
performed by MT, especially with regard to antioxidant
and anti-inflammatory activities.
Chemical structure and biological activities of melatonin
and its metabolites

MT, a multifunctional and the most effective antioxidant
among natural antioxidants, is endogenously produced
in plants and mammals as well as supplied to the body
through fruits and vegetables [1]. The compound is synthetized from tryptophan, mainly in the pineal gland in
the brain (about 80%) in darkness. Also, other sources
of MT in mammals are recognized: bone marrow cells,
retina, skin, platelets, lymphocyte, and the gastrointestinal tract [2, 22]. Four enzymatic steps of MT biosynthesis have been detailed: hydroxylation, decarboxylation,
acetylation, and methylation [2, 23]. In the first step,
tryptophan is metabolized by tryptophan hydroxylase
1 to 5-hydroxytryptophan. Next, the intermediate is
converted by the enzyme 5-hydroxytryptophan-decarboxylase to 5-hydroxytryptamine (serotonin). Further,
serotonin in mammals is metabolized to N-acetyl-5-hydroxytryptamine by serotonin N-acetyltransferase and
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methylated by the enzyme N-acetylserotonin O-methyltransferase to MT [23].
It is important to note that the intermediate compound
in the MT biosynthesis—serotonin is a key neurotransmitter having a wide spectrum of functions in the human
body [24]. For example, serotonin plays an essential role
in behavior and regulation of central nervous system.
MT modulates several functions, such as anxiety, psychological stress, learning, sleep, mood, pain, appetite,
and exhibits antioxidant and antidepressant properties,
among others. MT is carried by the systemic circulation
to central and peripheral tissues (e.g., liver, pancreas,
lung, kidney, heart, and the fetal adrenal gland) where
functions are organized through a 24-h cycle (so-called
circadian rhythms). Moreover, the neurohormone receptors are present in several central and peripheral tissues,
e.g., heart and coronary blood vessels, adrenal gland,
lung, kidney, prostate, skin, T and B lymphocytes, and
adipocytes.
Chemical structure of melatonin and its metabolites

Melatonin contains an electron-rich aromatic indole heterocycle with methoxy group attached to C5 atom and
amide group attached to C3 atom from indole ring [7, 25,
26] (Fig. 1).
The presence of an indole ring allows MT to function
as an electron donor, thus, to reduce level of electrophilic
species in cells. The site chains enable MT to exhibit both
hydrophilic and lipophilic properties and diffuse across
the cell membranes [27], thus, to protect biomolecules,
such as cytosol, mitochondria, and nucleus against oxidation [1, 9]. In addition, the methoxy and amide groups
enhance free radicals’ scavenging ability of the electronrich indole moiety, and the electronic structure of indole
ensures high resonance stability and its reactivity toward
ROS [8, 9, 28]. Evidence showed that C-atoms in the
indole ring structure are appropriate sites for hydroxyl
radical (HO⋅) and nitric oxide radical (NO⋅) acceptation
due to low energetic barrier, followed by adducts formation. Evidence simultaneously has suggested several
mechanisms responsible for the MT interaction with free
radicals [29] as follows: (a) an electron transfer reaction;
this interaction leads to the MT cation formation which
exhibits long lifetime and may react with O·−
2 ; (b) hydrogen atom donation, this capacity has been ascribed to the
NH group; (c) radical addition reaction, this process is
highly efficient with powerful electron acceptors efficacy;
in this way MT may deactivate two HO radicals; (d) substitution reaction, this process occurs on carbon atoms,
the C-atoms at position 2, 3 or 7 of the indole ring are
easily substituted by HO⋅; (e) nitrosation reaction, in this
process N-nitrosomelatonin is generated as a result of the
neurohormone reactivity towards NO.
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Fig. 1 Chemical structures of melatonin (MT) and its main metabolites: 3-OHMT (3-hydroxymelatonin); 6-OHMT (6-hydroxymelatonin); AMK (N1-ace
tyl-5-metoxyknuramine); AFMK (N1-acetyl-N2-formyl-5-metoksyknuramine)

Several distinctive activities of MT have been reported
due to its chemical structure. Briefly, evidence showed
enhancing DNA repair by affecting genes participated
in DNA damage [30, 31]. These properties enable MT to
scavenge peroxyl radical (ROO⋅), singlet oxygen (1O2) and
peroxynitrite (ONOO‾), and to inhibit the activity of NO
synthase and hypochlorous acid (HClO), among other
toxic radicals and species [1, 32]. The basic property that
distinguishes MT from other commonly applied antioxidants is its ability to scavenge up to ten of ROS/RNS, thus
MT is much more potent antioxidant than the classic
antioxidants, e.g., GSH or vitamins C and E which scavenger at most one radical [25]. Another distinctive property is transformation of MT on oxidative and enzymatic
pathways to several metabolites, which are widely recognized as good free radical scavengers [7, 32]. The main
metabolites of MT generated during its reaction with
ROS/RNS and/or on the enzymatic pathway, possessing
antioxidative properties, include 3-OHMT, 6-OHMT,
AMK, and AFMK as are shown in Fig. 1 [25, 28]. The MT
metabolites containing hydroxyl group in their chemical
structure exhibit lower potency in the scavenging ability
than MT and AFMK and AMK metabolites.

Biological activities of melatonin and its metabolites

Melatonin and its metabolites exhibit a wide spectrum of
both direct and indirect physiological effects in humans
[4, 25, 31–34] (Fig. 2). Firstly, these compounds scavenge
free radicals and other non-radicals ROS/RNS directly,
reducing level of OS, thus show antioxidant abilities
preventing inflammation. Secondly, these biomolecules
participate in immunomodulation, improve immune
defense, and exhibit other physiological activities, e.g.,
regulate circadian rhythms, body temperature, increase
physical performance and glucose uptake in muscles, and
prevent against lipid accumulation, among others [22,
35–38].
Free radical scavenging and anti‑inflammatory abilities
of melatonin

The main mechanism describing oxygen-based free
radical scavenging by MT occurs via electron donation.
For example, donation of an electron to HO⋅ leads to its
deactivation accompanied by the MT transformation to
almost non-toxic radical form (indolyl radical cation).
Further reactions of indolyl radical cation with HO⋅
leads to the formation of several hydroxylated products (e.g., 3-OHMT, 6-OHMT) also having antioxidant
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Fig. 2 Simplified scheme for the biological functions performed by melatonin

properties [7, 25, 26, 29]. Moreover, evidence shows
that the AFMK and AMK metabolites (Fig. 1) react with
HO⋅ in hydrophilic and lipophilic media at diffusion
controlled-rates ranging from 1.2 to 7.5 × 1010 M−1 s−1
and with trichloromethylperoxyl radical (⋅OOCCl3),
although they do not show reactivity towards hydroperoxy radical (HOO⋅) [32]. The reactivity of MT and
its derivatives exhibit continuous protection of biomolecules against OS, reducing concentration of the
most dangerous to cell radicals [26, 32]. The order of
the relative scavenging activity on the whole is as follows: AFMK > MT > AMK [1], although it is dependent
on the environment polarity [26]. In turn, the hydroxylated metabolites of MT, such as 2-HOMT formed during MT reaction with HClO as well as 4-OHMT and
6-OHMT not only directly scavenge free radicals, but
also through removing of transition metal ions in the
redox state (e.g., Fe2+, Cu+) diminish concentration of

HO⋅. Another important antioxidant property of MT is
decomposition of H2O2 and the ability to quench 1O2
[1, 39].
MT and its metabolites (3-OHMT, AFMK, and AMK)
also protect against metal toxicity acting as antioxidant
chelating agents on two manners: via direct chelation
mechanism and deprotonation reaction linked with
metal ion chelation [39]. It was found that the above
molecules completely inhibited OS induced by the
Cu2+—ascorbate mixture, and metabolite 3-OHMT
exhibited the highest efficiency [1]. The chelation activity of MT originates from the chemical structure, i.e.,
presence of two oxygen and two nitrogen atoms acting as di-, tri-, and tetra-dentate ligands with transition
metals [40]. MT and its metabolites prevent against a
free radical chain reaction of lipid peroxidation where
MT and its metabolites act as inhibitors of free radicals
initiating the lipid peroxidation, thus protect cells from
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the harmful effect of the peroxidation products containing a carbonyl group [41].
Further, MT and its metabolites possess ability to
reduce chronic and acute inflammation [34]. Although
inflammation is a natural response of the human
immune system to initiate stress stimuli acute and/or
chronic inflammation potentially leads to tissue damage of several organs and possibly to disease [42]. An
inflammatory process results from the loss of balance
between proinflammatory cytokines and anti-inflammatory agents’ levels towards activation of nuclear
factor κB (NF-κB) signaling [43]. The nuclear factor
penetrates the nucleus and binds to specific components modulating transcription of proinflammatory
genes [42].
MT and its metabolites can exert their anti-inflammatory effect through inhibition of the transcription
factors involved in proinflammatory cytokines generation, e.g., activator protein 1 (AP-1), hypoxia-inducible
factor-1α (HIF-1α), nuclear factor erythroid 2-related
factor2 (Nrf2), NF-κB, prostaglandin synthesis, reduction of production of adhesion molecules, infiltration
of neutrophils in tissue, decrease of COX-2 and inducible nitric oxide synthase (iNOS) expression as well
as by increasing superoxide dismutase (SOD), CAT,
glutathione peroxidase (GPx), and T-helper immune
response. These actions of MT reduce inflammation and decrease further ROS formation [22, 40]. For
this reason, MT is the antioxidant of great interest for
medicinal purposes as OS and chronic inflammation
are associated with an increased risk of several cancers
[44].
Another noteworthy beneficial property of MT is its
capacity to protect against cytotoxicity of heavy metals, such as lead, arsenic, chromium, cadmium, and
aluminum, induced through activation of basic regulators of antioxidant inflammatory pathways: NF-κB and
Nrf2. Evidence demonstrates their opposing actions:
Nrf2 regulates antioxidant pathway via promotion of the
transcription of antioxidant enzymes and cytoprotective genes, while NF-κB is the promotor of inflammatory
pathways; both transcription factors are regulated by
OS [45]. MT induces dissociation of Nrf2 from Keap-1
(Kelch-like ECH-associated protein), which can translocate into the nucleus, where it upregulates and promotes
the transcription of antioxidant genes. In addition, Nrf2
can also bind to NF-κB target genes and suppress their
transcription [40, 45]. The antioxidative, anti-inflammatory abilities of MT and its metabolites as well its high
lipophilicity also predispose this compound to reduce the
aging process, and age-related diseases, e.g., neurological
Alzheimer’s disease, Parkinson’s disease, or Huntington’s
disease, among others [9, 46].
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Anti‑tumor effect of melatonin

There is growing scientific evidence that both OS and
psychological stress have been linked with alterations in
the immune system responses. The disturbance manifests by a decrease in immune natural killer (NK) cells
activity and their ability to respond to the proinflammatory cytokines. NK cells and tumor antigen cytotoxic T
lymphocytes (CTLs) are important immune anticancer
agents of which activity is enhanced by MT. Activation
of CTLs by heat shock protein (HSP70), ATP and high
mobility group box1 (HMGB1) leads to the secretion of
anticancer cytokines, such as interferon gamma (IFNγ) and TNF-alpha which can induce apoptosis in cancer cells [47]. The hormone also reduces an activity of T
regulatory cells (Treg) and cancer-associated fibroblasts
of the agents recognized as promoters of the growth
and invasion of tumor cells [47]. Cancer cells show
over-proliferate ability through modulation of protein
expression and the signal transduction pathways such
as HIF-1, NF-κBs, phosphoinositide 3-kinase/protein
kinase B (P13K/AKT), insulin-like growth factor receptor
(IGF-1R), cyclin-dependent kinases and estrogen receptor signaling [48]. MT possess the ability to selectively
block the signaling pathways of tumor cells participating
in metastasis by modulation of cell–cell and cell–matrix
interactions and can restrain the proliferation of cancer cells and inhibit their growth [48, 49]. An important
property of MT is an ability of regulation of P13K/AKT
intracellular signaling pathway which is involved in the
promotion of metabolism, growth, proliferation, cells
survival, and angiogenesis. The P13K/AKT pathway is
overactive in many cancers reducing cells apoptosis [48].
Although the precise molecular mechanisms that would
allow MT to affect tumor initiation and progression are
not fully understood, several other beneficial effects have
been demonstrated, e.g., participation in maintaining
the genomic integrity, due to its antioxidant and inflammation activities, inhibition of androgen and estrogen
formation and activity and also their receptors, dysregulation of tumor metabolism [47, 48, 50]. The latter activity of MT results from its capacity to switch glucose
metabolism in cancer cells from the glycolytic anaerobic
category in the cytosol to a normal oxidative phosphorylation for ATP synthesis in the mitochondria and coverts pyruvate to acetyl-coenzyme A. In this way, MT can
decrease energy supply needed for ATP formation and
limit a rapid cancer cells growth and proliferation [44, 51,
52]. Evidence has demonstrated that in tumor cells glycolytic anaerobic metabolism definitely overweight the
oxidative metabolism; pyruvate formed in cytosol during
glucose metabolism is not transformed to the mitochondria but is metabolized to lactate in cytosol [Warburg
effect]. The Warburg effect limits the efficient production
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of ATP and citrate, which could arrest glycolysis as in
the normal cells, and, in addition, it prefers intracellular
alkaline environment, enhances glycolysis and cells cycle
progression, cancer cell growth, aggressiveness, resistance to apoptosis, and makes cancer therapy difficult [51,
52]. Evidence showed that the MT effect is concentration dependent as cancer cells showed the highest cytostatic glycolysis during the day and nighttime exposure to
light [51]. Findings have documented the oncostatic role
of MT against several types of cancer (breast, prostate,
oral, gastric, lung, brain, ovarian, colorectal, liver, renal)
[50, 53]. The compound has also been shown to be useful in cancer treatment during chemotherapy and radiotherapy [48, 54, 55]. The benefit in the MT application in
cancer therapy results from its different effects on tumor
cells and the normal cells. The use of MT in chemotherapy allows to reduce the dose of applied drugs to destroy
tumor cells through their increased sensitivity on drugs
interaction which limits their resistance [56]. In addition,
MT decreases side effects of the cancer chemotherapy,
increases rate of patients survival and improves overall
well-being. Similarly, combination of MT with radiotherapy has also been found to restrict damage of the normal
tissue related to radiation dose and achieve greater cancer inactivation; MT plays role of a radiosensitizer [54,
55].
Other physiological function of melatonin

Evidence documents that the primary physiological function of MT is to delivery information about
the diurnal cycle of light/darkness to the human body
and synchronization of central and peripheral oscillators distributed in tissues and organs [5, 57]. The circadian clock system plays a key role in maintenance
of homeostasis and human health. The circadian time
keeping system is composed of a generator of circadian
rhythms located in suprachiasmatic nuclei (SCN) of the
hypothalamus which synchronizes the peripheral cellular clocks with daily periodic environmental changes
[19]. This MT action as a time indicator to the biological clocks allows humans rapidly adept themselves to
environmental conditions and survive. This function
is important as the circadian rhythm disturbance can
increase the risk of metabolic, cardiovascular, and mental diseases, as well as cause poor quality of life [1, 2].
The circadian rhythm of the hormone synthesis and
secretion is closely related to the rhythm of sleep [58].
MT stabilizes circadian rhythms and exerts the chronobiotic effects acting on the plasma membrane trough G
protein-dependent receptors type 1 and type 2 called
MT1 and MT2, and its rhythmic release is regulated
by a central circadian rhythm generator [57, 59]. Density of MT1 and MT2 receptors in the SCN is high,
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although the receptors are also distributed in peripheral tissues and organs (e.g., adipose tissue, liver, heart).
The signals generated by SCN induce the MT synthesis
in darkness, and the process is controlled by SCN via
the sympathetic nervous system (SNS) [57].
Importantly, MT is effective in adjusting sleep–wake
cycles and improving the quality of sleep and is commonly used as a medicine for the treatment of sleep
problems, e.g., in insomnia, jet leg [60]. With age, the
production of MT decreases [22] which may have an
influence on poor sleep quality in elderly individuals
and cause the prevalence of comorbid the mental and
physical health disorders. The severity of sleep impairments correlate with the decrease of endogenous MT
formation and its concentration in cerebrospinal fluid
[22]. It is important to note that several MT receptor
agonists can also mimic MT activation, thus they are
able to regulate the body sleep–wake rhythm through
their actions on the MT receptors MT1 and MT2 in
the SCN. Ramelteon, agomelatine and tasimelteon are
representative MT receptor agonists used for sleep disorders [58, 60]. It is maintained that the MT receptor
agonist connecting to the MT1 receptor subtype can
directly improve sleep latency and quality, whereas the
agonist action on the MT2 receptor subtype positively
influences the circadian system, e.g., by promoting
early sleep. Also, the use of the MT receptors to treat
comorbid insomnia in several health disorders (neurological, metabolic, cardiovascular, psychiatric) is of
great importance [60–62]. The MT receptors agonists,
similarly as MT, have an influence on several signaling pathways, exhibit free radical scavenging ability,
stimulate the activity and/or expression of antioxidant
enzymes, and suppress the proinflammatory cytokines
release. For example, Wang et al. [61] reported that
ramelteon administration in C57BL/6 mice cells elevated traumatic brain injury, prevented against OS
and inflammation. In this study, treating with the MT
agonist significantly increased the expression of IL-4,
IL-10, SOD, GSH, GSH peroxidase and decreased levels
of IL-1β, TNF-α and MDA. The authors also observed
that ramelteon decreased KEAP1 expression of a key
sensor of oxidative and electrophilic stresses, promoted
Nrf2 nuclear accumulation, and increased levels of
heme oxygenase-1, that is Nrf2 regulated gene having
antioxidant and anti-inflammatory effect in vascular
cells. Ramelteon also controlled the redox controlling
enzyme NQO1 (NAD(P)H: quinone oxidoreductase
1) activity. NQO1 plays significant role in quinone
metabolism and exhibit the defense against OS [63].
Further, the reduced expression of proinflammatory
cytokines (IL-6, IL-1β, TNF-α), glial fibrillary acidic
protein and protection against increased expressions of
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proinflammatory COX-2 and against a potent inflammatory mediator prostaglandin 
E2(PGE2) as well as
excessive N O⋅ production were reported [62].
In addition to well-established functions outlined
above, MT has also been identified as an important promotor of a healthy metabolic rate through glucose homeostasis re-establishment and lipid metabolism regulation
[36]. These physiologic effects of the indolamine have
drawn great attention in the recent years [4, 5]. Evidence
shows MT can regulate glycogen breakdown to glucose,
preserve glycogen stores, improve insulin resistance in
the skeletal muscle and liver, and reduce obesity, protecting from several diseases caused by glycogen storage [6].
These MT properties influence physical performance
during PE of high intensity [64]. Although evidence on
the beneficial metabolic effects of MT is reported and
findings showed that the hormone exhibits very low side
effect [4], there is no full agreement in this respect (as
reviewed by Garulet et al. [37]). Detailed discussion of
the physiologic activities may be found in the reviews [4,
5, 36].

Physical exercise and melatonin
Proper sleep and recovery are essential to athletes’ benefit as well as enhancing their physical performance from
training programs. Evidence has accumulated showing that athletes commonly use sleep-enhancing supplements, and MT is one of the most used aid in this
respect, due also to other positive effects on the body,
e.g., as an antioxidant in protection of muscles against
OS and enhancer of performance [19].
Influence of physical exercise on cellular redox state

The effect of PE on the cellular redox homeostasis has
been widely studied since the 1970s, especially regarding exercise of moderate intensity (50–< 60% V Omax
2 ) and
exercise of vigorous/high intensity (≥ 60% V Omax
2 ). Independent of exercise type and intensity, exercise ≥ 50%
V Omax
induces an increase of ROS/RNS concentration
2
above physiological level, and their concentration is
dependent on several factors (e.g., exercise determinants,
postural position during exercise, state of training, age,
gender, and diet) [65]. During exercise non-mitochondrial sources of ROS are the main contributor to overall amounts of generated species in the skeletal muscle,
while during rest and recovery the mitochondrial source
is decisive [66].
There is significant evidence-based research carried
out during the past four decades that regular exercise of
moderate intensity is a key factor regulating the level of
ROS/RNS in a cell protection against chronic cell exposure to these species if their level is low [67, 68]. ROS/
RNS are formed constantly in various tissues even at rest
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as a part of normal metabolic processes. They play role
of secondary messengers in intracellular signaling, participate in gene expression, support cellular proliferation and relaxation of vascular smooth muscle cells, and
regulate angiogenesis, among others [12, 69]. Primarily,
PE increases mitochondrial metabolism and ROS/RNS
production, followed by an increase in stress resistance
and is responsible for variety of physiological adaptations
(e.g., mitohormesis) [70]. Further, regular moderate-tovigorous PE regulates the energy expenditure, insulin-like
growth factor-1 (IGF-1), and insulin-like growth factor binding proteins (IGFBPs) balance, defenses against
inflammation, and enhances the immune system functioning. Exercise improves metabolism of all the human
biological systems and cells as well as tissues tolerance to
higher concentration of ROS generated during exercise
training [71], enhancing activity of antioxidant enzymes
in muscles and mitochondrial biogenesis [9, 10].
Besides the beneficial effect of PE on humans, evidence
shows acute bouts of long-lasting and high-intensity
endurance exercises can cause biochemical and hormonal disturbance, generate ROS/RNS at the rate exceeding
the endogenous antioxidant system performance and disrupting redox homeostasis, i.e., induce OS in untrained
subjects [72]. In addition, diet poor in antioxidants
enhances the stress. Under such type of exercises the
maximal consumption of molecular oxygen in the muscle fibers may reach 100-fold increase compared with the
rest state. Then, skeletal muscles produce large amounts
of free radicals, ROS and RNS, including HO⋅ and NO⋅,
and are considered as the major source of these toxic species [14, 65, 66]. The increased production of the reactive species in muscles includes mainly mitochondrial
nicotinamide adenine dinucleotide phosphate (NADPH)
oxidase, phospholipase A2, and reactions catalyzed by
xanthine oxidase (XO), such as a breakdown of ATP
accompanied by generation of adenosine diphosphate
(ADP) and adenosine monophosphate (AMP) and further hypoxanthine via the adenylate kinase reaction [13,
14, 73]. Evidence summarizes possible adverse effects
of acute exercise and/or overtraining, such as DNA/
RNA and protein damage, increased lipid peroxidation,
decreased natural killer (NK) cells function and T cell
activities, increased angiogenesis, induction of protooncogenes, activation of transcription factors, alternation
in the muscle genome, the immune system damage, and
change of signal transduction [14, 66]. Acute reduction
of the muscle action and their fatigue was described to
high level of ROS produced during muscle contraction
[15, 65].
The damaging effect of OS has been confirmed experimentally by identifying changed level of OS markers
in blood and during muscle biopsies [74–76]. These
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processes may lead to chronic inflammation and increase
a risk of several civilization diseases, including cancer
development, progression and metastasis (more detailed
reviews on this topic are available, e.g., Ref. [71]). Evidence for the adverse oxidative modifications of muscular biomolecules were mainly reported after acute or
chronic anaerobic exercise [74, 77].
Acute high-intensity PE can cause biochemical and
hormonal disturbance, increase OS, being positively
correlated with overexpression of proinflammatory
cytokines, such as interleukin-1 (IL-1), interleukin-6 (IL6), tumor necrosis factor-alpha (TNF-α) and CRP [15].
Further, large changes in immune system activity and
lipid and carbohydrate metabolism following exhaustive
exercise can promote acute muscle inflammation and tissue damage [71]. Additionally, endurance athletes often
experience poorer quality of sleep, due to high training load [78]. Intense training also decreased athletes
endogenous MT level [79]. On the other hand, recent
studies demonstrated that the redox signaling pathway
participates in the chronic response of the skeletal muscle to endurance training [15, 79, 80]. This muscle activity
includes an uptake of glucose, influences on insulin sensitivity, mitochondrial biogenesis, and initiation of antioxidant enzymes [81, 82].
Effect of physical exercise on melatonin and serotonin
secretion
Melatonin secretion

Synthesis and secretion of MT is stimulated in darkness
and occur with circadian rhythm. Evidence has indicated
that the hormone concentration increases between 9:00
and 10:00 p.m. reaching a maximum value between 3.00
and 4.00 a.m. following by a decrease between 7:00 and
9:00 a.m. On average, the MT levels are estimated to be
about 5 pg/mL during the day and 50–100 pg/mL at the
night [83]. Synthesis and release of MT are modified by
several factors (genetic factors, sex hormones, age, diet,
light exposure, season, hypoxia, PE, diseases, drugs)
[83–85]. These factors may potentially act as enhancers
of MT secretion or its inhibitors. Briefly, increases in the
MT production and its secretion were reported for a diet
containing MT or the compounds supporting its synthesis, e.g., tryptophan, vitamins, and minerals that act as
activators or co-factors during the hormone synthesis
[85]. Further, extension of the dark phase during winter,
regularly taking antidepressants and MAO inhibitors also
increase the MT secretion [84]. Conversely, the presence
of light, especially the nocturnal exposure to artificial
light of blue cyanin color, use of β1-adrenergic blockers
and non-steroidal anti-inflammatory drugs, chronic alcohol consumption, and hypoxia have inhibitory effects.
Additionally, MT release is decreased during aging and in
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patients with long-term chronic diseases, such as dementia, type 2 diabetes mellitus, rheumatoid arthritis, cancer
[86]. Accumulated evidence presents the effect of PE on
human MT secretion as exercise induces an upregulation of many cell processes and physiological functions,
including the circadian clocks network synchronization
[19, 20, 87]. Studies that tested the magnitude and direction of the circadian rhythm phase shift induced by PE
showed that PE can both reduce and increase the MT
concentrations, according to the rhythm phase shifting (advanced or delayed) or remain without effect. This
interaction depends on the time of exercising during
the day, the intensity of light, training level, and exercise
determinants (intensity, duration, dose), regardless exercise type (aerobic, anaerobic, concentric, resistive) and
gender [88]. Two modes of the exercise effect on human
MT release have been observed rapid and delayed,
depending on its duration and daily repeatability [20].
Exercising in the late evening during ascending phase
of circadian MT release was accompanied by delaying
the hormone secretion, or even inhibition, depending on
exercise duration and intensity. In turn, when MT levels
reached the maximal physiological value, even exercise of
high intensity performed in early evening might enhance
MT release. There is a suggestion that exercising near
the offset of MT release or during the daytime (morning,
afternoon) did not exert significant changes in plasma
MT concentration. Further, among the circadian clock
system external stressors, which can interact or cooperate
with PE and modify neural activity and/or the circadian
genes expression and change the clock time are: light,
psychological stress, food, and PE. For this reason, it is
difficult to control all factors affecting the MT release,
and the data from literature are not yet consolidated. The
major stimuli responsible for the stressors influence on
the circadian clocks include glucocorticoids, sympathetic
nerves, OS, pH changes, decreased oxygen levels in the
local tissues, changed cytokines level, and temperature
[89]. Evidence has shown ROS activate the redox signal
transduction in the SCN and exhibit day–night variation controlling neuronal membrane excitability. Physical
exercise alters sympathetic neural activity and increases
MT release [19] caused by increased noradrenaline secretion during the sympathetic system stimulation [21].
Table 1 presents the representative data for the MT
secretion following PE. The studies varied in many
respects, as exercise duration (short time-from 1 to
8 days, long-lasting-from 2 to 12 months), exercise type,
exercise intensity (moderate, moderate-to-vigorous,
acute until exhaustion), training conditions (hypoxic,
normoxic conditions, indoor training, outdoor training),
sex, and measuring the timing of maximal secretion of
MT as well as the measurement methods. An increase

Ten healthy, sedentary males (average
age 22.2 ± 0.24 years)

Thirteen healthy, non-athletic males (aver‑ 20 min daily of moderate-intensity
age age 19–23 years)
exercise (running, 50–60% V Omax
2 ). Two
months exercise from 9:30 to 9:55 p.m.,
two months silent
MT measurements: 24 h prior to exercise,
48 h after exercise, two months after
the last exercise

RCT (n = 40) healthy men randomized
into four groups:
normoxia (n = 10), hypoxia (n = 10),
exercising under normoxia (n = 10),
exercising under hypoxia (n = 10),
(average age 22 ± 3 years). Observation
period 36 h

12 healthy males, regularly exercising, run‑ Three protocols: 30 min of steady state
nerslage (average age 20.7 ± 0.62 years)
running on a level treadmill at 75%
V Omax
2 morning exercise (9.00 a.m.),
afternoon exercise (4:00 a.m.), no exer‑
cise. Salivary MT detection: 8:00 p.m.,
10:00 p.m., 3:00 a.m. following exercise

Ten elite female netball athletes (average
age 23 ± 6 years)

Kilic et al. 2016 [94]

Zarei et al. 2016 [92]

De Aquino Lemos et al. 2018 [91]

Carlson et al. 2019 [90]

O’Donnell et al. 2019 [79]

Moderate-to-vigorous 12-month exercise
did not change level of 6-sulphatoxyme‑
latonin

No statistically significant changed con‑
centrations of 6-sulphatoxymelatonin
after 12-months exercises vs controls
(p = 0.66). Baseline metabolite levels
were significantly higher in women
compared to men, but not after
exercise

Long-lasting engaging in moderateintensity exercise caused decrease in MT
release, and increase in IL-17 cytokine
level

Significantly decreased salivary MT levels
in pre-training (6.2 pg/mL) and posttraining (17.6 pg/mL) vs a rest day (14.8
and 24.3 pg/mL), respectively)

Training caused significantly decreased
levels of MT

Exercising in the morning may increase
MT release compared with exercise
performed at afternoon

(2021) 71:27

MT melatonin, PE physical exercise, PBMCs peripheral blood monocular cells, RCT randomized controlled trial

Athletes one netball training session
over a 7-day period and one rest day
(control). Mean heart rate during train‑
ing—145 ± 10 bpm, mean rating of
perceived exertion—14 ± 1 according
to the Borg scale
MT detection: immediately pre-training,
7:15 p.m. and post-training 10:00 p.m.
and during control day

Significantly increased levels of MT at
03:00 a.m. compared with those at 8:00
and 10:00 p.m. after completed all the
protocol session. MT level at 10.00 p.m.
was significantly, elevated (by 20%)
after morning exercise vs afternoon
exercise

Aerobic moderate exercise on a treadmill Significantly increased nocturnal blood
PE under hypoxia enhances nocturnal level
at 50% of VT1 for 60 min, performed
MT levels in the hypoxia group vs the
of MT, influences its daytime level, and
under normoxia and hypoxia conditions
normoxia group after the second night;
improves sleep quality
from 11:00 a.m. to 12:00 noon blood
both values were lower than those in
MT detection: at 7:30 a.m. (the 1st and
the exercise group under hypoxia
2nd days), at 10:30 p.m. (the 1st and
2nd nights)

Significantly decreased MT levels in
PBMCs with exercise: post-exercise
7.94 ± 0.35 pg/mL, 2-month silent
6.05 ± 0.27 pg/mL vs pre-exercise
(9.16 ± 0.19 pg/mL). Significantly
increased IL-17 secretion by 39% in the
post-exercise time

Exhaustion PE did not affect the level of MT
in the blood, independently on exercise
timing (daytime, at night)

Author’s conclusion

Main results

Strenuous exercise as acute exercise until No statistically significant change
exhaustion, according to the Bruce
in serum MT levels after exercise
protocol (Cosmed T150 treadmill test).
performed during day or night vs the
Blood MT detection at rest, at 10:00
levels at rest: (3.63 ± 0.08 vs 3.37 ± 0.18
a.m. and immediately after exercise as
and 4.41 ± 0.26 vs 4.33 ± 0.21, pg/mL,
well as after 48 h at 12.00 p.m. (rest) and
respectively)
immediately after exercise

12-month program of moderate-tovigorous exercise (60 min daily, 6 days/
week at 60–80% V Omax
2 )
MT detection: baseline and 12-month
follow-up urinary metabolite of MT,
6-sulphatoxymelatonin

RCT (51 men, 49 women and 51 men
and 51 women as a stretching control
(average age 40–75 years, previously
sedentary)

Thrift et al. 2014 [93]

Category, timing of PE and MT
detection

Participant characteristics

Study, year

Table 1 The effect of physical exercise on melatonin levels in humans
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of MT concentration following PE in the morning [90]
and in hypoxic conditions [91], decreases in the same
[79, 92], and a lack of the effect [93, 94] were reported.
Referring to the MT measurement timing, Carlson et al.
[90] observed that exercise performed in the morning
resulted in elevated MT secretion by 20% compared to
the hormone secretion induced by the afternoon exercise. The representative studies listed in Table 1 have
some limitations, which have influenced their results.
These limitations include the lack of control for the major
factors influencing MT secretion, the small number of
measurement time points for MT detection or the small
sample size.
These findings remain in accordance with previous
findings because there is no clear consensus in the literature on the effect of PE on endogenous profile of MT
secretion [19].
It is noteworthy to present the quantitative impact of
some factors influencing the PE–MT release association.
For example, earlier experimental studies of Buxton et al.
reported both increases [20] and decreases [95] of MT
levels following exercise depending on time of day and
on intensity, duration, and type of exercise. The authors
found that during exercise in nighttime, when the MT
level is elevated and intensity of exercise is high, the hormone increase may reach 50%. Moreover, the MT secretion was found to be dependent on individual’s postural
changes. These researchers maintained that moderate
and high intensity exercise may influence MT levels and
involve the circadian clock phase-shifting effects. Also, a
study by Carr et al. [96] confirmed that plasma level of
MT was transiently increased in women during all acute
submaximal exercise tests of progressive endurance
training after 30-min exercise completion. A previous
study by Theron et al. [97] showed that additional factors,
such as BMI, lighting conditions, the time of day of exercising, and age may influence the relationship between
plasma MT concentration and PE. The authors demonstrated increased plasma MT level in adult Black males
who in the step-climbing exercise generated an energy
output of 185 W/m2 body surface area, immediately after
PE and 1 h after. Evidence indicated a threefold increased
MT mean level in group exercising under 320 lx lighting
(n = 15) and a 2.84-fold under 54 lx lighting (n = 15). Evidence exists that the season of year (winter, summer) also
affects the PE–MT association, and changes of MT concentration after exercise vs before exercise may depend
on the initial level of individual’s endogenous MT concentration [19]. An interesting observation done by Serrano and co-workers showed professional road cyclists
experienced of an adaptation to physical overloads during sports competitions [98]. It is maintained that this
ability allows them to regulate intracellular OS, limiting
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an induction of the proinflammatory cytokines. Moreover, elevated levels of MT detected after competition,
resulting from increased activity of SNS can give evidence that the protective effect of exercise operates via
modulatory effect on MT secretion [57, 99]. Although
processes responsible for the PE effect on MT secretion
are not fully understood, several mechanisms are proposed. As maintained above, one of the biogenic catecholamines—noradrenaline participates in regulation of
MT biosynthesis by the mammalian pineal gland [100].
Evidence presented high increases of noradrenaline level
(2 × 103%) in professional cyclists and even sevenfold
increase after half-marathon runs [101, 102]. Exercise
stimulates SNS activity and catecholamines (dopamine,
noradrenaline) release [21], thus it can modulate MT
secretion, followed by a net phase-shifting through the
pineal gland and SCN of the hypothalamus, which causes
an expression of receptors for MT. Further, PE stimulates
the midbrain raphe nuclei activating serotoninergic input
to the intergeniculate leaflets, which take part in the circadian function regulation through SCN [57]. It is suggested that an initiation of activity of the serotoninergic
neurons from the median raphe nuclei is excited by serotonin and depends on its concentration in SCN [103],
thus serotonin, a compound linked with well-being regulates the mammalian circadian rhythmicity.
Serotonin response to exercise

The body of evidence from animal models and human
studies demonstrated the beneficial effect of exercise
on brain functions [104, 105]. Regulations of the neurotransmitters is one of several exercise’s effect on brain
function, among others [104]. Evidence exist that PE
modulates serotonin system and can promote increased
concentrations of serotonin, as muscle activation needs
higher amounts of tryptophan [106]. The authors have
suggested that exercise reduces levels of amino acids
competing with tryptophan through muscle intake
and make these amino acids easier to cross the blood–
brain barrier into muscles. In this way, serotonin and
MT synthesis and their levels are increased in the brain
dependently on exercise intensity. The ability of PE to
modulate the activity of catecholaminergic and serotonergic systems and to enhance the brain function show
that exercise as a positive activating agent of body’ stress
response. Additionally, aerobic exercise has a high ability
to decrease depression and anxiety levels and to improve
physical performance [105].
Several recent reviews have summarized experimental
findings on the serotonin response to PE [104, 107, 108].
Most serotonin changes following exercise have been
well documented in rodents, but only a limited number
of human studies have been conducted. A review of 22
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studies in rats by Meeusen and De Meirleir presented
that the majority of analyzed studies found changes in
synthesis and metabolism of serotonin or its metabolites
and CATs in response to exercise [107]. Another review
by Basso and Suzuki [108] has analyzed research findings on the effect of exercise intensity and dose on serum
serotonin in humans and rodents. The authors have
suggested that acute long-term exercise increased serotonin levels and its metabolites in the frontal cortex, hippocampus, striatum, and midbrain as well as dopamine
in rodents. These reviews have maintained that the serotonin increase in the central nervous system of rodents
requires appropriate intensity of exercise, and the
amount of serotonin released is positively correlated with
PE intensity. Further, the findings of studies conducted in
humans show that individuals engaged in acute exercise
of low intensity may benefit from significant decreases
in depression and anxiety disorders in contrast to highintensity acute exercise, which is considered to contribute to fatigue. In this regard, it is maintained that a value
of exercise-induced ratio of serotonin to dopamine and
noradrenaline plays a significant role in the development of fatigue and performance [107, 108]. The authors
suggested that interaction between brain serotonin and
dopamine during acute PE can be responsible for the
brain region specific changes in levels of serotonin.
Statistically significant increases in blood serotonin
levels dependent on PE have also been reported in a few
experimental studies in humans and rodents in the last
decade [109–111]. A study by Valim et al. [109] showed
that women with fibromyalgia (n = 22) randomly divided
into two groups aerobic walking exercise and stretching exercise three times/week for 20 weeks experienced
statistically significant increase of serum serotonin concentration in response to aerobic exercise. Stretching
exercise resulted in statistically insignificant increase of
serotonin level. Also, a study by Arazi et al. [110] noticed
aerobic exercise significantly increased levels of serotonin
and dopamine in the physically active group of 16 men
addicted to opium in comparison to those who do not
exercise (n = 18). The active group was engaged in aerobic exercise—walking 2–3 times/week for 20–30 min.
The results show that even low-intensity aerobic exercise
can affect the levels of these neurotransmitters. Recently
these findings have been confirmed by Matsunaga et al.
in rats (n = 48) [111]. The researchers studied the effect
of intensity and timing of forced exercise (running on a
motorized wheel), voluntary exercise (free running on a
wheel) and low-dose exercise (voluntary, running exercise limited to 1 h), through 4 weeks on levels of serotonin. They found that response of serotonin to exercise
was exercise dose-dependent; significantly increased levels of serotonin and its metabolite (5-hydroxyindoleacetic
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acid) were seen in the dorsal and median raphe nuclei in
rats engaged in forced exercise. Also, increased concentrations of the neurotransmitter were found in the paraventricular hypothalamic nucleus and caudate putamen
in voluntary exercised rats. Low-dose exercise was without effect on serotonin levels, and the heavy exercised
rats experienced increased anxiety-like behavior.

Role of melatonin supplementation in response
to exercise‑induced oxidative stress
Exogenous compounds exhibiting antiradical and antioxidant potency play a key role in regulation of ROS/
RNS concentrations. Under OS conditions, endogenous
concentration of MT are unable to prevent damages to
biomolecules by ROS. Evidence shows supplementation
with appropriate antioxidants may improve the cellular
redox homeostasis, decrease oxidative modification of
DNA bases, lipids, and proteins, and decrease muscular
fatigue of athletes, thus enhance exercise performance
[112, 113]. It is known that antioxidant supplementation
is common practice among endurance athletes who hope
to minimize OS and enhance physical performance [49,
66, 114], and MT is a universal antioxidant that enjoys
great popularity among athletes.
Table 2 lists the representative studies (n = 11) for the
effect of MT ingestion on exercise-generated OS and
inflammation.
These observational studies differ from one another
mainly in terms of MT timing: taking MT before exercise [115–121] or before bedtime [122–125] and its dose,
exercise type, intensity, duration and timing, and training
level. The most common types of sport training in these
studies are cycle ergometer, treadmill exercise or running,
in which individuals mainly engaged in maximal or submaximal exercise. The authors performed measurements
of OS the markers (leukocytosis, MDA, 8-OHdG, TNF-α,
IL-6, LDL, AOPP), inflammatory markers (CRP, ALAT,
ASAD), TAS as well as of other endogenous antioxidants,
using mainly the blood sapless. The data indicate MT
intake reduced the markers of OS and inflammation in
athletes engaging in severe high-intensity exercise, independently of timing of MT intake. Only three [119–121]
of 11 presented experimental studies examined the MT
influence on redox status followed moderate-intensity
exercise. These authors found no effect of the hormone
(5–6 mg doses) on biochemical and hematological
parameters. This finding is in line with the evidence that
at least strenuous exercise and/or overload training cause
excessive production of ROS/RNS and an increase of OS
[64].
As presented above, in addition to antiradical, antioxidant activities and enhancing antioxidant enzymes
potency, the hormone can change glucose metabolism
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from glycolytic anaerobic category to a normal aerobic
mitochondrial oxidative phosphorylation for ATP synthesis. An ingestion of MT before exercise increases use
of glucose as a substrate energy. During prolonged exercise, glucose and fatty acids are utilized followed by a
reduction of glycogen in muscle and liver. Evidence has
shown that MT intake before PE preserves muscle glycogen stores of the compound which limits exercise performance [19].
Three of 11 presented studies [119, 120, 125] also
examined effects of MT supplementation on exercise performance, finding its improvement in the two
reported studies [119, 125]. In turn, a study by Souissi
et al. [121] tested the effect of MT supplementation on
inflammation induced by exercise at 60% V Omax
2 , i.e., the
lowest value of the maximum rate of O2 consumption for
exercise classified as high intensity. The authors found
increased levels of inflammatory markers in both the
MT-supplemented group and the placebo group and no
statistically significant differences between these groups.
A few studies presented in Table 2 examined also
endogenous MT level in athletics after high-intensity
training, observing significantly increased concentrations
of inflammatory markers (TNF-α, IL-6, IL-1Ra), isoprostane and 8-OHdG [115], malonaldehyde (MDA) [116,
118] or decreased blood levels of MT [116, 123], compared with control groups. Explaining the inconsistency
of the results may originate from different training status
of sportsmen, training protocols, and variability of their
redox state dependently on endogenous antioxidants
secretion.
It is worth noting that some studies on the effect of
strenuous exercise on cellular homeostasis observed
changes only in some OS markers, and even their lack
[15, 126]. Consistent with this finding, the current review
by Powers et al. [10] has presented a shape of a curve
illustrating the association between muscle fiber levels of ROS production induced by PE and physiological
function of these species. The curve exhibits biphasic
bell shape (hormesis, parabolic shape), with maximum
of physiological benefit corresponding to limited muscle
fatigue and exercise of moderate-to-vigorous intensity.
This part of hormesis describes the normal physiological
range of ROS, generated in the skeletal muscles by exercise and is considered as an important action to adapt
of individuals to endurance training. In turn, the second
phase of an association, described by the descending
part of hormesis curve, starts from the curve maximum,
and ends in the point corresponding zero of physiological functions, despite a further increase in exerciseinduced ROS generation. This part of hormesis suggests
that further increase in ROS level caused by prolonged
high-intensity exercise does not result in tissue damage,
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assuming that it is probably that PE exerts a true hormetic effect on the body [10].
In addition to MT supplementation, the level of
endogenous MT was seen to be dependent on daytime
performing PE and its dose. Although supplementation with MT showed high potency in reduction of
OS markers formed during intense exercise, the evidence is insufficient to recommend specific dose of
this antioxidant. These observations are in accordance with findings of other authors discussed earlier
and below. Briefly, there is clear consensus in the literature that noradrenaline is involved in biosynthesis of MT and can determine its concentration [100].
Increased secretion of the catecholamine in plasma
was observed above lactate threshold (on average of
50–80% of athletes’ V Omax
2 ) [21, 68] and was dependent not only on the level of training and duration, but
also on an individual’s psychological stress, health
state and muscular mass engaged in training [68]. An
experimental study by Kim and Kim [127], included
8-week-old rats that were subjected to high-intensity
(n = 30) and low-intensity (n = 30) exercises for 15 min
daily over 4 weeks, demonstrated greater increase in
blood MT concentration in rats exercising with highintensity exercise, compared to MT levels before and
after high- and low-intensity exercise. The authors have
maintained that MT secretion can be raised by exercise of high intensity, while exercise of low intensity
can exert pro-oxidative effect resulting in decreased
MT level due to the hormone interaction with stressors. This may explain, at least partially, the differences
in findings reported in Table 2. In turn, a review by
López-Flores et al., [128] of the research published
in 2000–2018 (18 articles) on the effect of MT intake
on sport performance underlined an important role
not only a MT dose, but also daytime the supplement
intake corresponding to the circadian clock system.
The researchers found that ingestion of MT up to 1 h
before PE did not improve athletic performance. The
authors maintain that a dose of 10 mg of MT consumed
30 min before sleep may increase the sport performance briefly. It was also suggested that supplementation with higher concentrations of this antioxidant at
the time of sport training may show adverse effects,
e.g., sleep deprivation and the SNS suppression. There
is increasing scientific evidence, mainly based on use of
vitamins C and E, lipoic acid, and coenzyme Q, showing that antioxidant supplementation at high doses may
be unfavorable for sport training adaptation because
exogenous antioxidants can impair ROS/RNS level in
skeletal muscle during sport training [129]. A previous
experimental study in vitro indeed showed that MT at
high concentration may also exert prooxidant activity

14 male healthy athletes (age: 20 mg MT/day or placebo
Training program combined
20–37 years) engaged in a
administered before exercise
strength and high intensity
2-week randomized, doubleduring the controlled study
interval trainings (6 sessions/
blinded trial (MT-treated
period (MT group)
week 60–75 min/day. V Omax
2 :
group and placebo-treated
70%, 90%)
group)

Two groups of sedentary
3 mg/day MT supplementation 8-week (3 days/week) exercise
women: involved in
before exercise training
training of increasing inten‑
exercise training and
sity and volume from 60 to
treated with MT (n = 10)
80% HRmax through 15 to
and only training (n = 10),
45 min
mean age: 24.2 ± 1.03 and
23.4 ± 1.83 years, respectively

Ortiz-Franco et al. 2017 [117]

Ziaadini et al. 2017 [118]

11 males moderately active,
mean age: 24.18 ± 3.92 years

Randomized double-blind
Experimental group supple‑
study of 24 resistance trained
mented with MT (100 mg
students (males). MT-treated
daily, 30 min before bedtime
men n = 12, placebo-treated
for 4 weeks)
men n = 12 (control group)

Leonardo-Mendonça et al.
2017 [122]

Beck et al. 2018 [119]

16 young male football players Experimental group treated
(experimental group n = 8,
with 6 mg MT, control group
control group n = 8)
treated with placebo, 30 min
prior to exercise

Maldonado et al. 2012 [116]

Results

MT (6 mg) or placebo inges‑
tion 30 min before exercise

MT supplementation can reduce
muscle damage via modula‑
tion of OS and preventing
overexpression of proinflam‑
matory cytokines

Conclusions

MT treatment strengthens
antioxidant state of athletes
and protects DNA from dam‑
age caused by high intensity
exercise

Exercise on cycloergometer
A time to exhaustion sig‑
MT supplementation enhanced
with initial workloads of 75 W
nificantly lower in placebo
aerobic tolerance but was
and increments of 15 W each
group compared to that with
without effect on the bio‑
3 min till exhaustion
MT administered by approxi‑
chemical and hematological
Maximal aerobic capacity
mately 19%
parameters
120.88 ± 18.78 W

Significantly increased levels
Supplementation with MT may
of MDA after long-lasting
decrease ROS levels, thus
aerobic exercise training.
improve lipid profile
Suppression of post-exercise
increased MDA in the exercis‑
ing and supplemented group

Significantly increased MT
level, TAC and GPx levels,
decreased DNA damage in
MT-treated group vs placebo
group after 2-week exercise

MT enhanced potency of the
endogenous antioxidant
system, restored redox equi‑
librium state and protected
against OS damage

Exercise increased MDA in
Supplementation with MT in
both groups, but significantly
acute sport training decreased
decreased in MT group after
the OS generated by exercise,
60 min of training. Decreased
enhanced the serum TAS, and
triglyceride and increased
improved metabolism of lipids
serum IgA levels after training
in MT group

8 sessions a week (about 10 h/ Increased ORAC levels by MT
week): 5 sessions-resistance
vs placebo after exercise.
training (3 sessions between
Reduced LPO, iNOS, GSSG/
60–75% of maximal strength
GSH and GPx/GRd ratios, CK,
and 2 sessions between
LDH, creatinine, cholesterol.
80 and 90% of maximal
Prevention against AOPP
strength), 2 sessions—weight increase in MT group vs
training and 1 session—aero‑
placebo group
bic running

Acute sport training of high
intensity (heart rate 135
beats per minute)

Oral intake of five tablets of
High intensity constant run
Significantly increased blood
3 mg MT: one tablet two
with several degrees of high
levels of TNF-α, IL-6, IL-1Ra,
days before the exercise test,
effort on total distance 50 km
urine 8-OHdG and isopros‑
three tablets on the previous
with permanent climbing,
tane concentrations in both
days and one tablet 1 h
altitude changing from 640
tested groups. Efficiently
before beginning the test
to 3393 m
reduced lipid peroxides,
TNF-α and 8-OHdG before
and after exercise in the MT
group vs placebo group

Highly trained performing
regular exercise amateur
athletes (n = 20): experimen‑
tal group (n = 10) supple‑
mented with MT and control
group (n = 10) receiving
placebo

Exercise measured

Ochoa et al. 2011 [115]

MT supplementation

Participant characteristics

Study, year

Table 2 Characteristics of the representative epidemiological studies on the effect of melatonin supplementation on exercise-induced oxidative stress in humans
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Eight healthy moderately
trained male students, mean
age: 21.8 ± 0.9 years

Randomized double-blind
trial of 14 healthy-trained
male athletes, mean age
154 ± 0.3 years

20 soccer players mean age
18.81 ± 1.3 years, MT group
(n = 10), placebo group
(n = 10)

Souissi et al. 2018 [121]

Cheikh et al. 2020 [124]

Farjallach et al. 2019 [125]

Exercise elevated inflamma‑
tory markers: CRP, LDH, ALAT,
ASAT in both placebo or MT
intake groups

Decreased blood MT levels
in footballers and rowers
vs controls before MT intake.
Increased serum MT level
in footballers and in rowers
after a 30-day MT intake.
Reduced OS markers: MDA,
IL-6, CRP, and low-density
lipoproteins

Running at 60% V Omax
2 for
45 min on a treadmill, start‑
ing at a speed of 8 km/h and
increasing by 0.5 km/h after
every minute

Athletes: exercise on a cycle
ergometer at 75% V Omax
2

No statistically significant
differences between both
groups in duration (com‑
pletion times: MT group
64.94 ± 5.95 min, placebo
group 65.26 ± 6.85)

Results

32.2 km cycling time trial
performance at V Omax
2
62.7 ± 6.8 (mL k g−1 min−1)
on ergometer. Mean pow‑
ers (190.4 ± 40.4 W and
190.0 ± 45.7 W, respectively)

Exercise measured

MT ingestion before moder‑
ate prolonged submaximal
exercise showed no antiinflammatory action

Supplementation of MT in
professional athletes during
intense training may protect
against the toxic action of
ROS/RNS and inflammation

Supplementation of MT did not
exhibit of significant effect on
performance in thermoneutral
environment

Conclusions

Intensive 6-day trainingrepeated sprint ability test:
sprints 6 × 40 m with a 20 s
of passive recovery between
repetitions

Decreased resting OS markers: Nocturnal MT intake during
AOPP, leukocytosis and CK.
intensive training decreased
Decreased post-exercise
OS, leukocytosis, cellular dam‑
leukocytosis and markers of
age, and improved exercise
cellular damage (CK, ASAT,
performance
ALAT), increased GPx and GR
activities in MT-treated group
vs placebo group

LY lymphocytes, WBC white blood cells, NE neutrophils, CRP C-reactive protein, CK creatine kinase, LDH lactate dehydrogenase, ASAT aspartate aminotransferase, MDA malonaldehyde, LDL low-density lipoprotein, V Omax
2
maximal oxygen uptake, ALAT alanine aminotransferase, CHO formaldehyde, ORAC oxygen radical absorption capacity, LPO lipid peroxidation, GSH glutathione, GSSG glutathione disulphide, AOPP advanced oxidation
proteins products, MT melatonin, GPx glutathione peroxidase, GR glutathione reductase, TACantioxidant status, iNOS inducible nitric oxide synthase, IL-1Ra, interleukin-1 receptor antagonist, 8-OHdG 8-hydroxy-2′deoxyguanosine

Nocturnal oral MT (5 mg)
or placebo ingestion in a
double-blind manner

10 mg MT or placebo ingestion Two-test sessions (separated
Reductions of: WBC, NE, LY, CRP, MT intake after strenuous late(control) after vigorous lateat least one week) Runningmuscle and hepatic damage
evening exercise diminished
evening exercise (10:00 p.m.)
Based Anaerobic Sprint Test
enzymes (CK, ASAD), LDH,
transient leukocytosis and
at 8:00 p.m. and in the follow‑ MDA and homocysteine
protected against lipid peroxi‑
ing morning (7:30 a.m.)
before and after strenuous
dation and muscle damage in
exercise vs placebo group
teenage athletes

6 mg MT supplementation
or placebo at 09:00 a.m. in
a randomized order 50 min
before exercise

5 mg MT administered before
sleep through 30 days in
the preparatory period for
athlete’s competition

Professional athletes: 47
football players, 19 rowers,
15 adults non-training males
(control group)

Czuczejko et al. 2019 [123]

MT supplementation
5 mg MT administered 15 min
before time trial. Controls:
placebo 15 min before time
trial

Participant characteristics

Brandenberger et al. 2018 [120] Ten cyclists long-distance
training, mean age
25.0 ± 4.0 years

Study, year

Table 2 (continued)
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[130]. The authors observed an increase of the amount
1
of HO⋅, O·−
2 and O2 generated in the Fenton-like reaction in the presence of high concentrations of MT. Further, animal’s study by Hong and colleagues reported
that MT treatment with nanomolar doses of rats with
the advanced knee osteoarthritis for 4 weeks alone or
combined with moderate treadmill exercise (30 min/
day) prevented periarticular muscle damage and cartilage degeneration [131]. The authors maintain that
these beneficial effects occurred through the circadian
clock system, due to restoring of clock-controlled genes
and correction of the abnormal chondrocyte phenotype. They observed higher reduction of serum TNF-α
when MT intake was combined with exercise. However, prolonged MT administration to rats resulted in
promotion of the proteolytic cleavage of receptor activator of nuclear factor kappa-B ligand (RANKL) protein in the synovium, followed by severe subchondral
bone erosion. In turn, an animal study by Gedikli and
co-workers [132] included MT injection (10 mg/kg) to
Sprague-Dawley rats and studied exposition to intense
exercise. The authors found cellular degenerations of
kidney and liver tissues in rats engaged in exercise and
a decrease in these damages in MT-treated rats. Evidence from rodents’ studies documents the important
regulatory and modulatory effects, supporting action of
MT supplementation on animals’ tissues, and skeletal
muscle exposed to OS stimuli, but these findings have
not yet been explored in humans. These findings show
that high-dose antioxidant supplements including MT
may be linked to health risk.
Another important and often discussed problem in this
research area concerns adaptation to OS in sport training. There is no clear consensus in the literature that
intake of antioxidants enhances adaptation to resistance
exercise training. To explain the research findings incompatibility, Merry and Ristow [129] have suggested the
possibility of a dose–response association between ROS/
RNS levels and exercise-training adaptation and physical performance as a hormetic response, i.e., a low dose
(physiological amounts) of OS stimuli such as ROS/RNS
exerts beneficial adaptive response of cells, whereas large
doses of the stressors exposition, by contrast, exhibit an
opposite effect (inhibition), i.e., a decrease of exercise
performance. Both PE and MT can exert the beneficial
effect through modulation and activation of stress resistance pathways, among others [133]. The dose–response
dependence finds confirmation that both MT and physical endurance training induce antioxidant enzymes
activities through increased mitochondrial content concentrations, and the Keap-1–Nrf2–ARE pathway and
NF-κB signal transduction as a response to OS and electrophilic stress [134, 135].
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Conclusions
This overview clearly summarizes the dispersed literature
findings on MT biosynthesis, its chemical and biological properties, discusses exercise-related redox signaling and intense exercise-induced disturbances in redox
homeostasis, provides the current knowledge on the
effect of exercise on MT release and the effect of MT
supplementation on endurance exercise-induced OS
in athletes. The available literature findings confirm an
important role of MT and its metabolites as a free radical
and ROS/RNS scavengers, protectors of DNA damage,
and reducers of the cellular and tissue oxidative damage.
Current evidence highlights a wide spectrum of MT antiinflammatory and antitumor actions, OS reduction, and
physiological effects on humans, such as circadian clock
network regulation, glucose and lipid homeostasis regulation, and effect on physical performance. Also, utility
of MT and its agonists for insomnia treatment has been
demonstrated. Strong evidence suggests mitochondria
are the central organelles for antioxidant actions of MT.
Physical exercise alters SNS activity and MT secretion.
The current evidence for the exercise dose–MT response
relationship showed conflicting findings, similar to previous findings, indicating the effect of PE on the exogenous
MT level in cells is extremely complex due to several factors increasing or decreasing its secretion as well as on
dependencies on many factors describing exercise, an
individual’s redox state, training status, environmental
conditions, MT intake timing, body mass, among others.
PE increases concentration of ROS/RNS followed by activation of protein kinases, transcription factors and gene
transcription, exerting beneficial adaptation or negative
effects on the human body, depending on dose and exposition time of cells to this exercise. Strong experimental
evidence is available for the positive effect of MT supplementation on lowering the proinflammatory cytokines,
lipid peroxides, C-reactive protein, and ROS/RNS of
which level could be strongly elevated in athletes engaged
in prolonged endurance exercise, independently on MT
supplementation timing. This compound has a potency
to increase level of antioxidant enzymes and the GSH/
GSSG ratio, thus to maintain the cellular redox homeostasis in athletes engaged in acute, high-intensity sports
training. Following this, epidemiological studies have
found utility of MT intake to be daytime-, dose-, and
exercise-dependent. The associations between PE, OS,
and MT supplementation are very complex; physiological level of ROS/RNS and PE of moderate intensity are
necessary to stimulate improvement of endogenous antioxidant system action.
Despite a large knowledge base on the beneficial properties of MT, the exact mechanism underlying its effect
on exercise-induced disturbance in redox homeostasis
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are not yet fully understood. Also, the current research
is not sufficient to indicate recommendations concerning effective but safe dose of MT intake by sportsmen.
Clinical studies are needed to establish optimal MT dose,
time of day and duration its supplementation to avoid
adversely affecting levels of ROS/RNS signaling and
consequently of the negative effect on exercise-training
organism adaptation.
As the reported studies, overall, included large variations of exercise program protocols and a small sample
of athletes, analyzed different markers of OS, were based
on a limited extent factors increasing/decreasing the hormone release, were different in terms of MT and exercise
timing and applied different MT doses, future research
is needed. New research should include larger samples
of athletes and address safe dose of MT intake and safe
exercise training programs for different sport categories.
In this sense, we hope that findings demonstrated in this
review will encourage the continuation of research in this
important health topic. The summarized and synthesized data of existing knowledge may help coaching staff
to incorporate safe sport-specific training program, MT
dose and timing. They may also be useful to research clinicians regarding the use of anti-inflammatory properties
of this compound in the treatment of inflammatory diseases, including COVID-19.
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